SHIVA TAJIANI: Open Payments
NPI 1417729252 · DAVENPORT, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,835 in 77 payments from 29 companies in 2025. Trend: 2023 $0 · 2024 $19 · 2025 $1,835
Food & beverage: $1,657Education: $178
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 8 | $249 |
| Novartis Pharmaceuticals Corporation | 9 | $199 |
| Celgene Corporation | 7 | $178 |
| Janssen Biotech, Inc. | 7 | $174 |
| GlaxoSmithKline, LLC. | 4 | $94 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $88 |
| AstraZeneca Pharmaceuticals LP | 3 | $86 |
| Merck Sharp & Dohme LLC | 4 | $83 |
| Regeneron Healthcare Solutions, Inc. | 3 | $79 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $57 |
Products named: KISQALI, ERLEADA, REBLOZYL, MONJUVI, LIBTAYO, OJJAARA, BREYANZI, KEYTRUDA.
Industry payments across FL — which companies pay providers there.
